Stingray Group (TSE:RAY.A – Get Free Report) had its target price boosted by Royal Bank of Canada from C$9.00 to C$10.00 in a research note issued on Tuesday, BayStreet.CA reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank of Canada’s target price would indicate a potential upside of 32.45% from the company’s current price.
A number of other equities analysts have also recently commented on the stock. Desjardins lifted their target price on shares of Stingray Group from C$9.00 to C$10.00 and gave the stock a “buy” rating in a research report on Thursday, February 8th. BMO Capital Markets increased their price target on shares of Stingray Group from C$7.00 to C$9.50 in a research note on Thursday, February 8th. Finally, CIBC increased their price target on shares of Stingray Group from C$8.00 to C$10.00 and gave the stock an “outperform” rating in a research note on Thursday, February 8th.
Read Our Latest Report on RAY.A
Stingray Group Price Performance
Stingray Group Company Profile
Stingray Group Inc provides business-to-business multi-platform music, and in-store music and video solutions to businesses and individuals worldwide. The company offers Stingray Music, which delivers music products and services on television (TV), Web, and mobile; Stingray Lite TV, a TV channel for pop music videos; Stingray iConcerts, a TV channel and an on-demand video service; Stingray Brava, a TV channel that provides operas and ballets, classical music performances, and local content; Stingray DJAZZ, a TV channel that features jazz concerts, films, portraits, and documentaries; Stingray Ambiance 4K, an ultra-high definition channel; and Stingray Karaoke that offers videos over the Internet and TV for TV service providers, as well as directly to consumers.
See Also
- Five stocks we like better than Stingray Group
- Transportation Stocks Investing
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Compound Interest and Why It Matters When Investing
- Hilton Demonstrates Asset Light is Right for Investors
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Stingray Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stingray Group and related companies with MarketBeat.com's FREE daily email newsletter.